November 25, 2015 - OrthoBuzz

FDA Approves Pradaxa for Thromboprevention After Hip Replacement

November 25, 2015 OrthoBuzz for Surgeons

The FDA this week approved dabigatran (Pradaxa) for prevention of DVT and pulmonary embolism following hip arthroplasty surgery. The approval follows FDA analysis of two

Day: November 25, 2015

FDA Approves Pradaxa for Thromboprevention After Hip Replacement